Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.
Gait termination in individuals with multiple sclerosis.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
Factors Associated with Employment Status in Individuals with Multiple Sclerosis.
The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series.
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.
miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting RORγt and STAT3.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
Baló's concentric sclerosis: imaging findings and pathological correlation.
C16 peptide shown to prevent leukocyte infiltration and alleviate detrimental inflammation in acute allergic encephalomyelitis model.
Iron accumulation in multiple sclerosis: an early pathogenic event.
Demographic and clinical factors associated with changes in employment in multiple sclerosis.
Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of abcd1-deficient mice.
Neurology issues in schizophrenia.
Multiple sclerosis and susceptibility to cardiovascular diseases: Implications of ethnicity-related interleukin-17A gene polymorphism?
Functional ionotropic glutamate receptors on peripheral axons and myelin.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Novel cerebrospinal fluid and serum autoantibody targets for Clinically Isolated Syndrome.
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
Pages
« first
‹ previous
…
493
494
495
496
497
498
499
500
501
…
next ›
last »